Evercore ISI reiterates IBM stock rating on Q1 beat expectations By Investing.com

Evercore ISI reiterated an Outperform rating and $345 price target on IBM ahead of its April 22 Q1 2026 earnings, expecting revenue of $15.6B and EPS of $1.81 to come in above consensus. The firm sees upside to IBM's 2026 outlook, with constant-currency revenue growth above 5% and software growth above 10%, supported by Confluent, mainframe strength, and Red Hat reacceleration. IBM's dividend remains well covered at $6.72 per share with a 2.65% yield, while investors will also watch AI, quantum, consulting signings, and cost-savings progress.

Analysis

IBM is a cleaner earnings-quality story than the market typically assigns to legacy large-cap software: the equity is being priced off low-teens growth optics, but the real driver is free-cash-flow durability plus operating leverage from software mix and acquisition synergies. If management raises medium-term constant-currency growth while reported growth stays muted, the setup favors multiple expansion because investors can look through FX noise and focus on recurring revenue quality and conversion.

The second-order winner is not just IBM itself but adjacent enterprise-software vendors with similar “infrastructure-to-platform” migration narratives; a credible acceleration in Red Hat/OpenShift and automation should pressure competitors that still depend on point-product seat expansion. Conversely, any signal that IBM is taking share via pricing or bundling would be a subtle negative for lower-defensiveness names in middleware, virtualization, and IT automation, especially those with weaker balance sheets and less installed-base leverage.

The key risk is that the market may already be front-running the beat-and-raise setup, so a clean print may not be enough if guidance only confirms rather than inflects. The real catalyst is a higher-quality 2026 outlook paired with unchanged or improved cash conversion; if that appears, the stock can rerate over the next 3-6 months, not just on the day of earnings. Downside is concentrated in any sign that consulting remains a drag or that acquisition contributions are masking underlying organic softness.

Contrarian view: consensus may be underestimating how much of IBM’s upside comes from mix, not top-line acceleration. If software growth re-accelerates while consulting remains merely stable, the market could be forced to revalue IBM more like a durable compounder than a cyclical services name, which opens room for multiple expansion without heroic revenue assumptions.

Key Decisions for Investors

• Long IBM into earnings via stock or May/June call spreads; best risk/reward is to own upside to a post-print guidance raise, with downside cushioned by recurring cash flow and dividend support.
• If already long IBM, consider a hedge with short basket exposure to lower-quality enterprise software/automation names over the next 1-3 months; a strong IBM guide would likely pressure weaker peers on share/growth concerns.
• After the report, add on any pullback only if 2026 constant-currency growth is revised higher and free-cash-flow guidance moves up; treat that as the signal that the multiple can expand for 2-4 quarters.
• Avoid chasing the name if the print is merely in-line; the trade works best when guidance creates a second-order re-rating, not when the quarter is simply better than feared.